Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
4/5/2023
AZ Signs 2nd Deal with Hong Kong Science Park to Drive Biotech, Medica...
4/4/2023
Pfizer, Meck Reportedly Slashed Prices of COVID-19 Pills in China
4/4/2023
Antibody-drug Conjugates Gain Traction in China Oncology Market: Globa...
4/4/2023
Sanofi Inks Vaccine Agreement in Shenzhen
4/4/2023
China Extends Raft of Preferential Tax Policies and Fee Cuts (China Br...
4/3/2023
Ablaze Pharma to Develop RayzeBio's GPC3-Targeted Radiotherapy
4/3/2023
BioNTech and DualityBio Form Global Strategic Partnership to Accelerat...
4/1/2023
China Further Intensifies Healthcare Cost Containment and Price Contro...
3/31/2023
Projections of Future Life Expectancy in China Up to 2035: A Modelling...
3/31/2023
CDE Issues the Working Procedures for Accelerating Evaluation of Marke...
3/31/2023
NSFC, Gates Foundation Launch Joint Fund to Improve Vaccine Regulatory...
3/31/2023
Recent Executive Moves
3/31/2023
Drug R&D and Product Registration News Digest March 2023 (5)
3/31/2023
Financial-related Company News Digest (March 2023)
3/30/2023
AstraZeneca, KYM Biosciences Complete Licensing Deal for Anticancer Dr...
3/30/2023
Apollomics Announces Closing of Business Combination and Listing on Na...
3/30/2023
IQVIA: Chinese Retail Pharmacy Sales up 5.2% in MAT Q4/2022
3/30/2023
China Continued to Dominate the Hurun Global Rich List 2023, Highlight...
3/30/2023
Central Government Issues the Notice on Further Facilitating Medical E...
3/30/2023
Boehringer Ingelheim Remains Confident of Its China Prospects Despite ...
3/30/2023
Rxilient and Junshi form JV to Develop and Commercialize Toripalimab i...
3/29/2023
JPO Publicizes 8th VBP Tender Outcome, Which Cuts Average Price by 56%
3/29/2023
Investing in China's Healthcare Sector (China Briefing)
3/28/2023
Uptake of Hepatitis C Direct-Acting Antiviral Treatment in China: A Re...
3/28/2023
CDE Issues the Technical Guidelines for the Application of Physiologic...
3/28/2023
NHSA Issues the NHSA Notice on Improving the Price Formation Mechanism...
3/28/2023
Chinese Scientists Develop New Vaccine Strategy by Entrapping Live Vir...
3/27/2023
BioNTech and Oncoc4 Sign Strategic Collaboration for Novel Checkpoint ...
3/27/2023
NCC: China's Tumor Registration System Covers 1.407B Population
3/27/2023
AstraZeneca to Further Expand R&D Presence in China
Page:
51
/
719
Total number of articles:
21546
:
[First]
[<<]
[49]
[50]
[51]
[52]
[53]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit